back to the BIVI product listing
Description
Lysigin® is a lysed culture of highly antigenic polyvalent somatic antigen containing phage types I, II, III, IV and miscellaneous groups of Staph aureus.
Features
- Extensively tested in controlled studies and in field studies.
- Contains five different phage types of Staph aureus.
- Includes capsular serotypes 5, 8, 336.
Benefits
- Up to three times higher spontaneous cure rates over cows receiving no vaccine.
- Reduces chronicity of infection when a vaccination program starts at an early age.
- Allows cows opportunity to reach their genetic potential for milk production.
- Reduces culling.
Advantages
Lysigin is produced from five phage types of Staph aureus and includes capsular serotypes 5, 8, 336.
Dosage & Administration
Using aseptic technique inject a single 5 mL dose IM in cattle. Repeat in 14 days. Follow with a single 5 mL booster dose each 5 to 6 months. Start vaccinating all heifers at 6 months of age.
Precautions
Store out of direct sunlight at a temperature between 35° - 45° F (2° - 7° C). Avoid freezing. Shake well before using. Use entire contents when first opened. Do not vaccinate within 21 days before slaughter. Anaphylactoid reactions may occur.
Antidote: Epinephrine.
Antidote: Epinephrine.
Uses
Lysigin is recommended for vaccination of healthy, susceptible cattle against mastitis caused by Staph aureus.
Highlights
- Contains five different phage types of Staph aureus.
- Includes capsular serotypes 5, 8, 336.
- Efficacy tested and proved in controlled and field studies.
Files
Ref PDF:
Label PDF:
MSDS PDF:
Additional Documents:
